Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

From Architecture to Brain Imaging to Leader of a Major Academic Health System: John Mazziotta Talks with Johannes Czernin About an Evolving Career and Its Origins in Nuclear Medicine.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

The Research Post.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Prognostic Value of PSMA PET-Derived Tumor Burden Stratification in Metastatic Hormone-Sensitive Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Dosimetry Analysis of <sup>177</sup>Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

The Patient Post.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Breast cancer.

Johannes Czernin1, Matthias R Benz, Martin S Allen-Auerbach

  • 1Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA. jczernin@mednet.ucla.edu

Methods in Molecular Biology (Clifton, N.J.)
|February 19, 2011
PubMed
Summary
This summary is machine-generated.

Positron emission tomography (PET) and PET-computed tomography (CT) are valuable tools for diagnosing, staging, and monitoring breast cancer treatment. These imaging techniques aid in personalized cancer care and the development of new molecular imaging agents.

Related Experiment Videos

Last Updated: Jun 4, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Area of Science:

  • Oncology
  • Radiology
  • Nuclear Medicine

Background:

  • Diagnostic imaging is crucial for accurate cancer diagnosis, staging, and treatment monitoring.
  • Positron emission tomography (PET) and PET-computed tomography (CT) offer high accuracy in characterizing tumors and assessing disease progression.

Purpose of the Study:

  • To discuss the role and contributions of (18)F-fluorodeoxyglucose PET and PET-CT in breast cancer management.
  • To introduce novel molecular imaging probes and devices in early clinical research.

Main Methods:

  • Review of existing evidence on PET and PET-CT in breast cancer care.
  • Discussion of applications in diagnosis, staging, restaging, and treatment monitoring.
  • Overview of emerging molecular imaging technologies.

Main Results:

  • PET and PET-CT demonstrate high accuracy in diagnosing and characterizing breast tumors.
  • These imaging modalities effectively support disease staging, restaging, and monitoring therapeutic response.
  • Novel imaging probes and devices show promise for future clinical applications.

Conclusions:

  • PET and PET-CT are essential tools for comprehensive breast cancer management.
  • These imaging techniques guide individualized treatment strategies and improve patient outcomes.
  • Continued research into novel molecular imaging holds potential for advancing breast cancer care.